Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06784765Not ApplicableRecruiting

Preventive Use of PIPAC in Locally Advanced Gastric Cancer.

Role: lead

NCT06724276Not ApplicableActive Not Recruiting

Combined Treatment for Non-Healing Wounds in Chronic Lower Extremity Arterial Disease: a Comparative Study

Role: collaborator

NCT05222893Not ApplicableCompleted

Optimization of PEEP During Laparoscopic Surgery

Role: collaborator

NCT06273826Recruiting

"Colorectal Leakage App" for Early Detection of Anastomotic Leakage After Colorectal Surgeries

Role: lead

NCT04702685Phase 3Unknown

Erector Spinae Plane Block With Ropivacaine for Major Upper Abdominal Surgery

Role: collaborator

All 5 trials loaded